BCAX (Bicara Therapeutics) Institutional Ownership: 111.96% (As of Jun. 30, 2026)


BCAX Bicara Therapeutics Inc BCAX
12 GF Score
Price $29.30
! 3 Warning Signs
View Full Analysis

What is Bicara Therapeutics Institutional Ownership?

Bicara Therapeutics BCAX -0.24% 12 Institutional Ownership is 111.96% as of Jun. 30, 2026. GuruFocus rates BCAX with a GF Score™ of 12/100. The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bicara Therapeutics's institutional ownership is 111.96%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bicara Therapeutics's Insider Ownership is 1.23%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bicara Therapeutics's Float Percentage Of Total Shares Outstanding is 71.59%.

Bicara Therapeutics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Bicara Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bicara Therapeutics Institutional Ownership Chart

Bicara Therapeutics Historical Data

The historical data trend for Bicara Therapeutics can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31
Institutional Ownership 23.28 24.26 25.51 27.21 37.22 36.29 33.73 36.29 36.53 37.08
BCAX
12GF Score
Bicara Therapeutics Inc BCAX
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bicara Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 111.96% mean?
Bicara Therapeutics (BCAX) has a Institutional Ownership of 111.96% as of Jun. 30, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Bicara Therapeutics and its competitors.
Is Bicara Therapeutics' Institutional Ownership too high?
Bicara Therapeutics' current Institutional Ownership is 111.96%. Overall, Bicara Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bicara Therapeutics' Institutional Ownership compare to ZYME and SRPT?
Bicara Therapeutics' Institutional Ownership of 111.96% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Bicara Therapeutics and its competitors. Bicara Therapeutics's current Institutional Ownership is 111.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bicara Therapeutics stock overvalued right now?
Bicara Therapeutics (BCAX) has a current Institutional Ownership of 111.96%. The current Institutional Ownership is 111.96%. Bicara Therapeutics' overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Bicara Therapeutics (BCAX), the current Institutional Ownership is 111.96% as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bicara Therapeutics Business Description

Address 116 Huntington Avenue, Suite 703, Boston, MA, USA, 02116
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. The company's goal is to build a fully integrated, commercial-stage biopharmaceutical company that develops important therapies for people living with cancer, starting with ficerafusp alfa.
12GF Score

Get the complete analysis for BCAX

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$29.30
Price